-
Something wrong with this record ?
Effects of a GABA-B receptor agonist baclofen on cortical epileptic afterdischarges in rats
P Mares, J Lindovsky, R Slamberova, H Kubova
Language English Country France
NLK
Free Medical Journals
from 1999 to 1 year ago
- MeSH
- Baclofen pharmacology therapeutic use MeSH
- Financing, Organized MeSH
- GABA Agonists pharmacology therapeutic use MeSH
- Rats MeSH
- Cerebral Cortex drug effects physiopathology MeSH
- Treatment Failure MeSH
- Receptors, GABA-B drug effects MeSH
- Severity of Illness Index MeSH
- Seizures drug therapy physiopathology MeSH
- Check Tag
- Rats MeSH
- Male MeSH
Inhibition mediated by GABA-B receptors can play a role in epilepsy. We therefore studied its involvement in cortical epileptic afterdischarges in adult rats by means of a GABA-B receptor agonist baclofen. Three different experiments were performed with cortical epileptic afterdischarges and an additional experiment studied possible effect of baclofen on cortical interhemispheric (transcallosal) evoked potentials. Baclofen was administered intraperitoneally in doses of 3 or 6 mg/kg. In contrast to a marked proconvulsant action of a GABA-B receptor antagonist baclofen did not exhibit clear anticonvulsant action against EEG afterdischarges but a moderate effect on motor phenomena was observed. On the contrary, it tended to decrease threshold intensities for individual epileptic phenomena. Augmentation of postictal refractoriness by baclofen was found only with a short poststimulation interval (2 min). Cortical interhemispheric responses induced by single pulses were influenced only moderately by baclofen; paired-pulse potentiation induced by short intervals between stimuli was not changed but there was a depression of the second response induced 200 and 250 ms after the first one with the 6 mg/kg dose of baclofen. Failure of baclofen to exhibit an expected anticonvulsant activity might be due to a complexity of GABA-B inhibitory system (pre- as well as postsynaptic localization of GABA-B receptors).
- 000
- 03026naa 2200409 a 4500
- 001
- bmc11002970
- 003
- CZ-PrNML
- 005
- 20111210202144.0
- 008
- 110225s2007 fr e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a fr
- 100 1_
- $a Mareš, Pavel, $d 1937- $7 jo20000074131
- 245 10
- $a Effects of a GABA-B receptor agonist baclofen on cortical epileptic afterdischarges in rats / $c P Mares, J Lindovsky, R Slamberova, H Kubova
- 314 __
- $a Department of Developmental Epileptology, Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic. maresp@biomed.cas.cz
- 520 9_
- $a Inhibition mediated by GABA-B receptors can play a role in epilepsy. We therefore studied its involvement in cortical epileptic afterdischarges in adult rats by means of a GABA-B receptor agonist baclofen. Three different experiments were performed with cortical epileptic afterdischarges and an additional experiment studied possible effect of baclofen on cortical interhemispheric (transcallosal) evoked potentials. Baclofen was administered intraperitoneally in doses of 3 or 6 mg/kg. In contrast to a marked proconvulsant action of a GABA-B receptor antagonist baclofen did not exhibit clear anticonvulsant action against EEG afterdischarges but a moderate effect on motor phenomena was observed. On the contrary, it tended to decrease threshold intensities for individual epileptic phenomena. Augmentation of postictal refractoriness by baclofen was found only with a short poststimulation interval (2 min). Cortical interhemispheric responses induced by single pulses were influenced only moderately by baclofen; paired-pulse potentiation induced by short intervals between stimuli was not changed but there was a depression of the second response induced 200 and 250 ms after the first one with the 6 mg/kg dose of baclofen. Failure of baclofen to exhibit an expected anticonvulsant activity might be due to a complexity of GABA-B inhibitory system (pre- as well as postsynaptic localization of GABA-B receptors).
- 650 _2
- $a Animals
- 650 _2
- $a baklofen $x farmakologie $x terapeutické užití $7 D001418
- 650 _2
- $a mozková kůra $x účinky léků $7 D002540
- 650 _2
- $a mozková kůra $x patofyziologie $7 D002540
- 650 _2
- $a GABA agonisté $x farmakologie $x terapeutické užití $7 D018755
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a receptory GABA-B $x účinky léků $7 D018080
- 650 _2
- $a záchvaty $x farmakoterapie $x patofyziologie $7 D012640
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a neúspěšná terapie $7 D017211
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Lindovský, Jiří. $7 xx0232729
- 700 1_
- $a Šlamberová, Romana $7 xx0052834
- 700 1_
- $a Kubová, Hana, $d 1959- $7 xx0036699
- 773 0_
- $t Epileptic Disorders $w MED00154920 $g Roč. 9, Suppl 1 (2007), s. S44-S51 $x 1294-9361
- 910 __
- $a ABA008 $b x $y 1
- 990 __
- $a 20110413113306 $b ABA008
- 991 __
- $a 20110413113306 $b ABA008
- 999 __
- $a ok $b bmc $g 830382 $s 694961
- BAS __
- $a 3
- BMC __
- $a 2007 $b 9 $c Suppl 1 $d S44-S51 $i 1294-9361 $m Epileptic disorders $n Epileptic Disord $x MED00154920
- LZP __
- $a 2011-2B/dkme